Skip to content
healthcare.dev

LEQSELVI

NDC 47335-108, deuruxolitinib phosphate, tablet, film coated, from Sun Pharmaceutical Industries, Inc..

Product NDC
47335-108
Status
Listed
Labeler
Sun Pharmaceutical Industries, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA217900
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/47335-108 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEURUXOLITINIB PHOSPHATE8 mg/1

Pharmacologic classes

Bile Salt Export Pump Inhibitors [MoA]; Breast Cancer Resistance Protein Inhibitors [MoA]; Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]; Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]; Organic Anion Transporter 3 Inhibitors [MoA]

Package NDCNDC-11Package
47335-108-864733501088660 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (47335-108-86)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a603f231-d09e-4bad-ad5e-b55f865da095

Use it

Look up 47335-108 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/47335-108 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 47335-108. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.